Patents by Inventor Bernhard Lindenthal

Bernhard Lindenthal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intrauterine delivery system for contraception
    Patent number: 10532025
    Abstract: The invention relates to a method for contraception and for reducing menstrual problems and inducing amenorrhea, wherein an intrauterine delivery device is used for the controlled release of a combination of progestogen or a drug having a progestogenic activity and at least one therapeutically active substance capable of preventing or suppressing abnormal and/or irregular endometrial bleeding over a prolonged period of time.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: January 14, 2020
    Assignee: Bayer Oy
    Inventors: Bernd Duesterberg, Manja Ahola, Jyrki Pihlaja, Heikki Lyytikäinen, Harri Jukarainen, Satu Kleemola, Tero Parkatti, Tuula Valo, Ina Gröticke, Bernhard Lindenthal, Ulrike Fuhrmann
  • INTRAUTERINE DELIVERY SYSTEM FOR CONTRACEPTION
    Publication number: 20180263899
    Abstract: The invention relates to a method for contraception and for reducing menstrual problems and inducing amcnorrhca, whcrcin an intrauterine delivery device is used for the controlled release of a combination of progestogen or a drug having a progestogenic activity and at least one therapeutically active substance capable of preventing or suppressing abnormal and/or irregular endometrial bleeding over a prolonged period of time.
    Type: Application
    Filed: May 18, 2018
    Publication date: September 20, 2018
    Applicant: Bayer Oy
    Inventors: Bernd Duesterberg, Manja Ahola, Jyrki Pihlaja, Heikki Lyytikäinen, Harri Jukarainen, Satu Kleemola, Tero Parkatti, Tuula Valo, Ina Gröticke, Bernhard Lindenthal, Ulrike Fuhrmann
  • Intrauterine delivery system for contraception
    Patent number: 9999592
    Abstract: The invention relates to a method for contraception and for reducing menstrual problems and inducing amenorrhea, wherein an intrauterine delivery device is used for the controlled release of a combination of progestogen or a drug having a progestogenic activity and at least one therapeutically active substance capable of preventing or suppressing abnormal and/or irregular endometrial bleeding over a prolonged period of time.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: June 19, 2018
    Assignee: Bayer Oy
    Inventors: Bernd Duesterberg, Manja Ahola, Jyrki Pihlaja, Heikki Lyytikäinen, Harri Jukarainen, Satu Kleemola, Tero Parkatti, Tuula Valo, Ina Gröticke, Bernhard Lindenthal, Ulrike Fuhrmann
  • Pharmaceutical composition for emergency contraception
    Patent number: 9907806
    Abstract: The invention relates to pharmaceutical compositions for emergency contraception, to the use of levonorgestrel in combination with COX inhibitors for the preparation of pharmaceutical compositions for the stated purpose, and to a method for preparing these pharmaceutical compositions.
    Type: Grant
    Filed: December 12, 2014
    Date of Patent: March 6, 2018
    Assignee: BAYER INTELLECTUAL PROPERTY, GmbH
    Inventors: Bernhard Lindenthal, Rolf Schürmann, Sascha General
  • METHOD OF CONTRACEPTION
    Publication number: 20170312219
    Abstract: The invention is related to an improved method of contraception, for preventing or suppressing abnormal and/or irregular endometrial bleeding and achieving a rapid induction of amenorrhea by using an intrauterine delivery system comprising controlled release levonorgestrel over a prolonged period of time and at a therapeutic level required for contraception, and a sufficient amount of NSAID capable of suppressing abnormal and/or irregular endometrial bleeding
    Type: Application
    Filed: July 14, 2017
    Publication date: November 2, 2017
    Applicant: Bayer Oy
    Inventors: Bernd Duesterberg, Manja Ahola, Jyrki Pihlaja, Heikki Lyytikäinen, Harri Jukarainen, Satu Kleemola, Tero Parkatti, Tuula Valo, Ina Gröticke, Bernhard Lindenthal, Ulrike Fuhrmann
  • Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
    Patent number: 9655887
    Abstract: The invention relates to a pharmaceutical composition for non-hormonal, on-demand contraception and to processes for preparing this pharmaceutical composition. The latter comprises 2H-indazole as novel EP2 receptor antagonists in combination with COX inhibitors. The invention furthermore provides a method for non-hormonal female-controlled on-demand contraception where a pharmaceutical composition comprising EP2 receptor antagonists in combination with COX inhibitors is taken on demand prior to expected sexual intercourse.
    Type: Grant
    Filed: May 16, 2014
    Date of Patent: May 23, 2017
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Bernhard Lindenthal, Nico Bräuer, Peter Serno, Andrea Rotgeri, Ulrike Fuhrmann, Bernd Buchmann, Anne Mengel, Ulrike Röhn, Antonius Ter Laak
  • Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception
    Patent number: 9579330
    Abstract: The invention relates to a method of hormonal female controlled “on demand” contraception, in which a pharmaceutical preparation comprising a COX inhibitor and levonorgestrel is taken on demand prior to expected sexual intercourse. Further subjects of the invention relate to pharmaceutical compositions and application regimes for “on demand” contraception.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: February 28, 2017
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Bernhard Lindenthal, Katrin Waellnitz, Peter Serno, Stefanie Lindemann, Ulrike Fuhrmann
  • INTRAUTERINE DELIVERY SYSTEM
    Publication number: 20160262923
    Abstract: The present invention relates to an improved method of contraception which addresses the problems of initial bleeding and spotting associated with the use of intrauterine delivery systems, and to an improved intrauterine delivery system.
    Type: Application
    Filed: October 14, 2014
    Publication date: September 15, 2016
    Applicant: Bayer Oy
    Inventors: Manja AHOLA, Christine TALLING, Bernhard LINDENTHAL, Ulrike FUHRMANN, Lüder M. FELS, Katja PRELLE, Norbert SCHMEES
  • USE AND APPLICATION REGIMEN OF A PHARMACEUTICAL COMPOSITION CONTAINING LEVONORGESTREL AND A COX INHIBITOR FOR ON-DEMAND CONTRACEPTION
    Publication number: 20160000805
    Abstract: The invention relates to a method of hormonal female controlled “on demand” contraception, in which a pharmaceutical preparation comprising a COX inhibitor and levonorgestrel is taken on demand prior to expected sexual intercourse. Further subjects of the invention relate to pharmaceutical compositions and application regimes for “on demand” contraception.
    Type: Application
    Filed: November 19, 2013
    Publication date: January 7, 2016
    Inventors: Bernhard LINDENTHAL, Katrin WAELLNITZ, Peter SERNO, Stefanie LINDEMANN, Ulrike FUHRMANN
  • -indazoles as EPreceptor antagonists
    Patent number: 9062041
    Abstract: The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP2-receptor.
    Type: Grant
    Filed: November 26, 2012
    Date of Patent: June 23, 2015
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Nico Bräuer, Anne Mengel, Ulrike Charlotte Röhn, Andrea Rotgeri, Bernd Buchmann, Bernhard Lindenthal, Antonius Ter Laak
  • PHARMACEUTICAL COMPOSITION FOR EMERGENCY CONTRACEPTION
    Publication number: 20150105359
    Abstract: The invention relates to pharmaceutical compositions for emergency contraception, to the use of levonorgestrel in combination with COX inhibitors for the preparation of pharmaceutical compositions for the stated purpose, and to a method for preparing these pharmaceutical compositions.
    Type: Application
    Filed: December 12, 2014
    Publication date: April 16, 2015
    Inventors: Bernhard LINDENTHAL, Rolf SCHÜRMANN, Sascha GENERAL
  • Pharmaceutical composition for emergency contraception
    Patent number: 8921345
    Abstract: The invention relates to pharmaceutical compositions for emergency contraception, to the use of levonorgestrel in combination with COX inhibitors for the preparation of pharmaceutical compositions for the stated purpose, and to a method for preparing these pharmaceutical compositions.
    Type: Grant
    Filed: June 10, 2010
    Date of Patent: December 30, 2014
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Bernhard Lindenthal, Rolf Schürmann, Sascha General
  • Novel 2H-Indazoles as EP2 Receptor Antagonists
    Publication number: 20140336172
    Abstract: The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP2-receptor.
    Type: Application
    Filed: November 26, 2012
    Publication date: November 13, 2014
    Inventors: Nico Bräuer, Anne Mengel, Ulrike Röhn, Andrea Rotgeri, Bernd Buchmann, Bernhard Lindenthal, Antonius Ter Laak
  • PHARMACEUTICAL COMPOSITION FOR EMERGENCY CONTRACEPTION
    Publication number: 20120172343
    Abstract: The invention relates to pharmaceutical compositions for emergency contraception, to the use of levonorgestrel in combination with COX inhibitors for the preparation of pharmaceutical compositions for the stated purpose, and to a method for preparing these pharmaceutical compositions.
    Type: Application
    Filed: June 10, 2010
    Publication date: July 5, 2012
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Bernhard Lindenthal, Rolf Schürmann, Sascha General
  • Extended Benzamide Derivatives as Modulators of the EP2 Receptor
    Publication number: 20100029598
    Abstract: The present invention relates to extended benzamide derivatives of the general formula I, to processes for preparation thereof and to use thereof for production of pharmaceutical compositions for treatment of disorders and indications associated with the EP2 receptor.
    Type: Application
    Filed: July 24, 2009
    Publication date: February 4, 2010
    Applicant: Bayer Schering Pharma AG
    Inventors: Marcus Kopitz, Bernhard Lindenthal, Antonius Ter Laak, Tim Wintermantel, Olaf Peters, Gernot Langer, Nico Braeuer, Bernd Buchmann
  • Indolylamides as modulators of the EP2 receptor
    Publication number: 20100029599
    Abstract: The present invention relates to indolylamide derivatives of the general formula (I), to processes for preparation thereof and to use thereof for production of pharmaceutical compositions for treatment of disorders and indications associated with the EP2 receptor.
    Type: Application
    Filed: July 29, 2009
    Publication date: February 4, 2010
    Applicant: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
    Inventors: Marcus Koppitz, Antonius Ter Laak, Tim Wintermantel, Bernhard Lindenthal, Nico Bräuer, Gernot Langer, Bernd Buchmann
  • 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
    Patent number: 7563924
    Abstract: The present invention relates to 9-chloroprostaglandin derivatives of the general formula I which may be advantageous for the treatment of fertility problems.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: July 21, 2009
    Assignee: Schering Aktiengesellschaft
    Inventors: Bernd Buchmann, Daryl Faulds, William Guilford, Gernot Langer, Judy Li, Bernhard Lindenthal, Werner Skuballa, Luisella Toschi
  • Indolylalkylthienopyrimidylamines as modulators of the EP2 receptor
    Publication number: 20090042913
    Abstract: The present invention relates to indolylalkylthienopyrimidylamines of the general formula I, to processes for their preparation and to their use for production of pharmaceutical compositions for treatment of disorders and indications connected to the EP2 receptor.
    Type: Application
    Filed: July 11, 2008
    Publication date: February 12, 2009
    Inventors: Nico BRAEUER, Bernd Buchmann, Marcus Koppitz, Olaf Peters, Antonius Ter Laak, Bernhard Lindenthal, Gemot Langer, Tim Wintermantel
  • SUBSTITUTED ACETAMIDES AS MODULATORS OF THE EP2 RECEPTOR
    Publication number: 20090042882
    Abstract: The present invention relates to substituted acetamides of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP2 receptor.
    Type: Application
    Filed: June 12, 2008
    Publication date: February 12, 2009
    Inventors: Bernd BUCHMANN, Nico Braeuer, Olaf Peters, Knut Eis, Marcus Koppitz, Bernhard Lindenthal, Gernot Langer, Tim Wintermantel, Antonius Ter Laak
  • THIENOPYRIMIDYLAMINES AS MODULATORS OF THE EP2 RECEPTOR
    Publication number: 20090042878
    Abstract: The present invention relates to thienopyrimidylamines of the general formula I, to processes for their preparation and to their use for production of pharmaceutical compositions for treatment of disorders and indications connected to the EP2 receptor.
    Type: Application
    Filed: July 10, 2008
    Publication date: February 12, 2009
    Inventors: Nico BRAEUER, Bernd Buchmann, Marcus Koppitz, Olaf Peters, Antonius Ter Laak, Bernhard Lindenthal, Gernot Langer, Tim Wintermantel